Literature DB >> 16125929

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.

Sara Gandini1, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi.   

Abstract

A systematic meta-analysis of observational studies of melanoma and family history, actinic damage and phenotypic factors was conducted as part of a comprehensive meta-analysis of all major risk factors for melanoma. Following a systematic literature search, relative risks were extracted from 60 studies published before September 2002. Fixed and random effects models were used to obtain pooled estimates for family history (RR = 1.74, 1.41-2.14), skin type (I vs. IV: RR = 2.09, 1.67-2.58), high density of freckles (RR = 2.10, 1.80-2.45), skin colour (Fair vs. Dark: RR = 2.06, 1.68-2.52), eye colour (Blue vs. Dark: RR = 1.47, 1.28-1.69) and hair colour (Red vs. Dark: RR = 3.64, 2.56-5.37), pre-malignant and skin cancer lesions (RR = 4.28, 2.80-6.55) and actinic damage indicators (RR = 2.02, 1.24-3.29). Sub-group analysis and meta-regression were carried out to explore sources of between-study variation and bias. Sensitivity analyses investigated reliability of results and publication bias. Latitude and adjustment for phenotype were two study characteristics that significantly influenced the estimates.

Entities:  

Mesh:

Year:  2005        PMID: 16125929     DOI: 10.1016/j.ejca.2005.03.034

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  191 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Sun damage in ultraviolet photographs correlates with phenotypic melanoma risk factors in 12-year-old children.

Authors:  Ryan G Gamble; Nancy L Asdigian; Jenny Aalborg; Victoria Gonzalez; Neil F Box; Laura S Huff; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Lori A Crane; Robert P Dellavalle
Journal:  J Am Acad Dermatol       Date:  2012-03-09       Impact factor: 11.527

3.  Personal attributions for melanoma risk in melanoma-affected patients and family members.

Authors:  Jennifer Hay; Marco DiBonaventura; Raymond Baser; Nancy Press; Jeanne Shoveller; Deborah Bowen
Journal:  J Behav Med       Date:  2010-09-01

4.  Increased risk of second primary cancers after a diagnosis of melanoma.

Authors:  Porcia T Bradford; D Michal Freedman; Alisa M Goldstein; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2010-03

5.  Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

Authors:  Julia A Newton-Bishop; Yu-Mei Chang; Mark M Iles; John C Taylor; Bert Bakker; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Faye Elliott; Peter A Kanetsky; Mark Harland; Jennifer H Barrett; D Timothy Bishop
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

6.  MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Peter Kanetsky; Richard P Gallagher; Colin B Begg; Robert C Millikan; Terence Dwyer; Stefano Rosso; Loraine D Marrett; Nancy E Thomas; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2010-08-19       Impact factor: 2.506

7.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

8.  Randomized controlled trial of a sun protection intervention for children of melanoma survivors.

Authors:  Ellen R Gritz; Mary K Tripp; Susan K Peterson; Alexander V Prokhorov; Sanjay S Shete; Diana L Urbauer; Bryan M Fellman; Jeffrey E Lee; Jeffrey E Gershenwald
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10       Impact factor: 4.254

Review 9.  The discovery and development of binimetinib for the treatment of melanoma.

Authors:  Brian Tran; Mark S Cohen
Journal:  Expert Opin Drug Discov       Date:  2020-04-04       Impact factor: 6.098

10.  Update on the Epidemiology of Melanoma.

Authors:  Steven T Chen; Alan C Geller; Hensin Tsao
Journal:  Curr Dermatol Rep       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.